Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly M Thompson

Showing results (51-60 of 180) with videos related to

Pageof 18
Sort By:
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 30, 2020
Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Borno and Yobe in Northeast NigeriaDominika A Kalkowska, Kimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 24, 2015
Modeling Measles Transmission in the North American Amish and Options for Outbreak ResponseKimberly M Thompson, Kasper H Kisjes
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 17, 2015
Systematic Review of Measles and Rubella Serology StudiesKimberly M Thompson, Cassie L Odahowski
Risk Analysis : an Official Publication of the Society for Risk Analysis|August 8, 2015
The Costs and Valuation of Health Impacts of Measles and Rubella Risk Management PoliciesKimberly M Thompson, Cassie L Odahowski
Risk Analysis : an Official Publication of the Society for Risk Analysis|February 16, 2021
Health and Economic Outcomes Associated with Polio Vaccine Policy Options: 2019-2029Dominika A Kalkowska, Kimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|September 22, 2018
Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and AfghanistanRadboud J Duintjer Tebbens, Kimberly M Thompson
Future Microbiology|November 11, 2016
The potential benefits of a new poliovirus vaccine for long-term poliovirus risk managementRadboud J Duintjer Tebbens, Kimberly M Thompson
BMC Infectious Diseases|September 26, 2015
Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needsRadboud J Duintjer Tebbens, Kimberly M Thompson
The Journal of Infectious Diseases|August 26, 2017
Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining TransmissionKimberly M Thompson, Radboud J Duintjer Tebbens
The Journal of Infectious Diseases|August 26, 2017
Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining SerotypesKimberly M Thompson, Radboud J Duintjer Tebbens
Pageof 18

Showing results (51-60 of 180) with videos related to

Sort By:
Pageof 18
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 30, 2020
Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Borno and Yobe in Northeast NigeriaDominika A Kalkowska, Kimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 24, 2015
Modeling Measles Transmission in the North American Amish and Options for Outbreak ResponseKimberly M Thompson, Kasper H Kisjes
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 17, 2015
Systematic Review of Measles and Rubella Serology StudiesKimberly M Thompson, Cassie L Odahowski
Risk Analysis : an Official Publication of the Society for Risk Analysis|August 8, 2015
The Costs and Valuation of Health Impacts of Measles and Rubella Risk Management PoliciesKimberly M Thompson, Cassie L Odahowski
Risk Analysis : an Official Publication of the Society for Risk Analysis|February 16, 2021
Health and Economic Outcomes Associated with Polio Vaccine Policy Options: 2019-2029Dominika A Kalkowska, Kimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|September 22, 2018
Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and AfghanistanRadboud J Duintjer Tebbens, Kimberly M Thompson
Future Microbiology|November 11, 2016
The potential benefits of a new poliovirus vaccine for long-term poliovirus risk managementRadboud J Duintjer Tebbens, Kimberly M Thompson
BMC Infectious Diseases|September 26, 2015
Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needsRadboud J Duintjer Tebbens, Kimberly M Thompson
The Journal of Infectious Diseases|August 26, 2017
Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining TransmissionKimberly M Thompson, Radboud J Duintjer Tebbens
The Journal of Infectious Diseases|August 26, 2017
Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining SerotypesKimberly M Thompson, Radboud J Duintjer Tebbens
Pageof 18